Abdominal fat radiodensity, quantity and cardiometabolic risk: The Multi-Ethnic Study of Atherosclerosis

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
Ravi V ShahVenkatesh L Murthy

Abstract

Fat radiodensity, as measured by fat attenuation on computed tomography (CT), has emerged as a potential biomarker of "fat quality." We sought to characterize the relationship between fat radiodensity and quantity in subcutaneous, visceral, and intermuscular fat depots, and its role in inflammation, insulin resistance, and metabolic syndrome (MetS). We studied 1511 individuals from the Multi-Ethnic Study of Atherosclerosis who underwent CT for measurement of regional fat distribution and radiodensity, along with biomarker assessments and adjudication of incident metabolic syndrome (MetS). Linear, logistic and Cox regression analyses were used to measure association between fat radiodensity and (1) fat quantity, (2) biomarkers of cardiometabolic dysfunction, and (3) both prevalent and incident MetS. In each fat depot, radiodensity was strongly and inversely associated with quantity (e.g., visceral fat radiodensity vs. quantity: ρ = -0.82, P < 0.01). After adjustment for age, sex and race, lower visceral fat radiodensity was associated with greater C-reactive protein, leptin and insulin, but lower adiponectin (P < 0.01 for all). After full adjustment for cardiovascular disease risk factors, visceral (but not subcutaneous or inter...Continue Reading

References

May 1, 1995·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Oct 25, 2002·American Journal of Epidemiology·Diane E BildRussell P Tracy
Dec 18, 2003·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Dec 18, 2003·The Journal of Clinical Investigation·Haiyan XuHong Chen
Feb 4, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Shingo BabaRichard L Wahl
Sep 20, 2012·JAMA : the Journal of the American Medical Association·Ian J NeelandJames A de Lemos
Jan 24, 2013·JAMA : the Journal of the American Medical Association·Ian J NeelandJames A de Lemos
May 15, 2013·JACC. Cardiovascular Imaging·Klara J RosenquistCaroline S Fox
May 29, 2013·The American Journal of Cardiology·Matthew A AllisonJoao A Lima
Aug 30, 2014·Journal of the American Heart Association·Nicholas J AlveyCaroline S Fox
Sep 23, 2014·Nature Communications·Miyako TanakaYoshihiro Ogawa
Dec 3, 2014·JACC. Cardiovascular Imaging·Ravi V ShahMatthew A Allison
Jun 11, 2015·The Journal of Clinical Endocrinology and Metabolism·Aaron J YeohCaroline S Fox

❮ Previous
Next ❯

Citations

Jan 30, 2018·Diabetes, Obesity & Metabolism·Prince DadsonPirjo Nuutila
Jun 14, 2019·Obesity Surgery·Gian Franco AdamiRenzo Cordera
Dec 22, 2017·Journal of the Endocrine Society·Ilaria BarchettaMaria Gisella Cavallo
Jul 6, 2020·Alimentary Pharmacology & Therapeutics·Maryam EbadiAldo J Montano-Loza
Feb 13, 2019·BMC Medical Imaging·Louis Mullie, Jonathan Afilalo
Sep 14, 2020·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Prince DadsonPirjo Nuutila
Mar 2, 2021·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Perry J PickhardtRonald M Summers
Sep 15, 2018·Obesity Research & Clinical Practice·Chantal A Vella, Matthew A Allison

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.